-->

Small-Cap Footwear Power Stock Sidesteps Market Sell-Off

Post a Comment
Turn Your Images On

The Stock Power Podcast

Small-Cap Footwear Power Stock Sidesteps Market Sell-Off

Matt Clark, Research Analyst

When I was a journalist, you wouldn’t find me at my desk often.

I was out and about covering my beat.

I needed suitable footwear. Not any old tennis shoe would do.

But it was tough to find something that was both comfortable and professional looking.

That leads me to the 98-rated Power Stock I have for you in this episode of The Stock Power Podcast.

This company makes some of the most comfortable dress shoes on the market.

Find out why its “maximum momentum” will continue.

Turn Your Images On

Suggested Stories:

Quality Factor Helps Stocks Weather Bear Markets — Look at JNJ!

Cannabis Mailbag: Where Jushi Stock (JUSHF) Goes From Here


FROM OUR PARTNERS

Gold Is SOARING — Here's What You Need to Do

Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in for less than $10.

MORE here…

Money & Markets Poll

Are You in the Market for a New Car?

Thank you for your participation in last week's poll!

We’re all feeling inflation right now, so it was interesting to see the response from viewers like you.

A chunk of you said that you are experiencing inflation in the car market. Let’s expand on that with this week’s poll.

We want to know who's shopping for a car.

Vote in this week's poll here.  

Turn Your Images On

Suggested Stories:

Dividend Growth Fights Inflation — 2 Keys to Spot Top Stocks

The Fed’s Real Inflation Target Is Bad News for Stocks


FROM OUR PARTNERS

Buy This Next-Gen Crypto Before Its Big Upgrade

Experts predict this one crypto will soar 7,200% by the end of the decade … and grow 20X bigger than bitcoin. But you must get in before its big upgrade.

Details here.

Turn Your Images On

1983: Amgen (Nasdaq: AMGN) filed its IPO at $18 per share. After a 60% drop during its first five months of public trading, the stock took three years to get back to its initial market cap of $190 million. Today, Amgen is worth $130 billion, making it one of the largest biopharmaceutical companies.


   


Privacy Policy
The Money & Markets, P.O. Box 8378, Delray Beach, FL 33482.

To ensure that you receive future issues of Money & Markets, please add info@mb.moneyandmarkets.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance.

The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: https://moneyandmarkets.com/contact-us/

Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Money & Markets expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Money & Markets, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.

(c) 2022 Money & Markets, LLC. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 800-684-8471)

Remove your email from this list: Click here to Unsubscribe

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter